Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Study Details page for NCT02657889 shows no significant changes between screenshots; core information about the TOPACIO trial appears unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T20:49:51.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operation status notice; removed the v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:15:48.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added v3.1.0 and removed the Ovarian cancer resource; older v3.0.2 revision reference was present. Overall, versioning and resource scope changed.
    Difference
    0.3%
    Check dated 2025-09-29T02:59:53.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top link was removed; this is a minor UI change with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-14T18:59:12.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-07T14:27:21.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, while also removing some specific cancer-related resources and topics. Notably, the page now includes new information on ovarian cancer treatments and related topics.
    Difference
    3%
    Check dated 2025-08-31T11:44:03.000Z thumbnail image

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.